HT update: spotlight on estradiol/norethindrone acetate combination therapy
Colleen Casey, Christine A Murray · Clinical Interventions in Aging · 2008
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Clinical Interventions in Aging · Dove Medical Press · article · 2008
Abstract
Abstract: The goal ofpostmenopausal hormone therapy is to alleviate the symptoms that are associated with the loss of estrogen. Many formulations of estrogen and progestin are available, depending on the needs and circumstances of each individual woman. For postmenopausal women, the choice of whether or not to begin therapy requires knowledge of the risks and benefits of estrogen and/or progestin replacement. The purpose of this review is to describe the risks and benefits of hormonal therapy, focusing on estradiol/norethindrone acetate combination therapy.
Open the resolved locator · 10.2147/cia.s1663
Metadata licence: OpenAlex metadata (CC0)